Open buy, fifth week
Gilead climbs 5.6%, hits two of three targets and pushes the stop above entry
Our view last week
Gilead stock closes the week up 3.9%, bouncing off its own 20-day moving average and pushing back toward its recent highs. The price is now inside the No-Trade Zone, one step from the breakout level that would confirm the move higher. The healthcare sector stays strong (XLV +5.7% for the month), and the buy signal, now in its fourth week, keeps the weekly uptrend intact — even as its push cools a little.
This week's summary
Gilead closes the week up 5.6%, lifted by a healthcare sector in real strength (XLV +4.3% for the week) and by a clean technical structure: all four structural moving averages aligned, price above the 50-week moving average, and a sequence of higher daily lows. The buy signal, now in its fifth week, has already reached two of the three price targets from our most advanced model, and the dynamic stop now sits above entry: the gain is already locked in. The signal's push, though, keeps fading.
IQS Phase
76
in tension
Signal Strength
29
low · fading
Sizing
MINIMUM
Ranking
#156 / 167
US stocks in progress
Trade P&L %
+8.82%
from signal to date, no stop loss
Rank position
ranks 156th among the 167 Longs already running for US stocks in our ranking, with a signal strength of 29 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein strong phase
Performanceweekly +4.33% · monthly +9.53%
GILD belongs to the health care sector (reference ETF XLV). The sector is classified in strong phase according to our weekly reading.
restricted Platinum content